| Dr Jason M Fixler, MD | |
|
2401 W Belvedere Ave, Dept Of Pediatrics, Baltimore, MD 21215-5216 | |
| (410) 601-5864 | |
| (410) 601-8766 |
| Full Name | Dr Jason M Fixler |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 2401 W Belvedere Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205885605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D59527 (Maryland) | Secondary |
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | D59527 (Maryland) | Primary |
| Entity Name | Sinai Hospital Of Baltimore, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043235666 PECOS PAC ID: 0941112346 Enrollment ID: O20031104000353 |
News Archive
Italian Researchers say they have found what they believe to be the first direct link between high cholesterol levels and prostate cancer.
Through an innovative use of cell phone records, researchers at UCLA, the University of Miami and Cal State, Fullerton, have found that women appear to avoid contact with their fathers during ovulation.
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
Three stakeholder groups agree that regulators are not adequately prepared to manage the risks posed by nanotechnology, according to a paper published in the peer-reviewed journal PLOS One. In a survey of nano-scientists and engineers, nano-environmental health and safety scientists, and regulators, researchers at the UCSB Center for Nanotechnology in Society (CNS) and at the University of British Columbia found that those who perceive the risks posed by nanotechnology as "novel" are more likely to believe that regulators are unprepared.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason M Fixler, MD 2401 W Belvedere Ave, Attn: Credentialing, Baltimore, MD 21215-5216 Ph: (410) 601-5524 | Dr Jason M Fixler, MD 2401 W Belvedere Ave, Dept Of Pediatrics, Baltimore, MD 21215-5216 Ph: (410) 601-5864 |
News Archive
Italian Researchers say they have found what they believe to be the first direct link between high cholesterol levels and prostate cancer.
Through an innovative use of cell phone records, researchers at UCLA, the University of Miami and Cal State, Fullerton, have found that women appear to avoid contact with their fathers during ovulation.
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
Three stakeholder groups agree that regulators are not adequately prepared to manage the risks posed by nanotechnology, according to a paper published in the peer-reviewed journal PLOS One. In a survey of nano-scientists and engineers, nano-environmental health and safety scientists, and regulators, researchers at the UCSB Center for Nanotechnology in Society (CNS) and at the University of British Columbia found that those who perceive the risks posed by nanotechnology as "novel" are more likely to believe that regulators are unprepared.
› Verified 9 days ago
Hilary Tamara Wolf, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-7373 Fax: 410-328-7305 | |
Dr. Carmel Bogle, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 443-287-0526 Fax: 410-955-0897 | |
Anna Eunjoo Choe, Pediatrics Medicare: Medicare Enrolled Practice Location: 615 N Wolfe St Rm Wb602, Baltimore, MD 21205 Phone: 410-955-3362 Fax: 410-614-1582 | |
Dr. Melissa Lauren Shapiro, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2411 W Belvedere Ave Ste 407, Baltimore, MD 21215 Phone: 410-601-8663 | |
Dr. Alexander James Jaksic, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 781-223-0948 | |
Adam J Spanier, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Armory Pl, Baltimore, MD 21201 Phone: 410-225-8780 Fax: 410-225-8766 | |
Milagritos D Tapia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6749 Fax: 410-328-6136 |